Cargando…
Hepatotoxicity associated with the use of teriflunomide in a patient with multiple sclerosis: A case report
RATIONALE: Teriflunomide is an inhibitor of pyrimidine synthesis available as a first-line treatment for relapsing-remitting multiple sclerosis. Drug-induced liver damage is a relevant problem in clinical practice, representing a frequent cause of treatment discontinuation. This case report describe...
Autores principales: | Ferreira, Cristiane Munaretto, de Vasconcelos-Pereira, Erica Freire, de Oliveira, Vanessa Marcon, Salgado, Pedro Rippel, Domingos, João Américo, Monreal, Maria Tereza Ferreira Duenhas, Guerra-Shinohara, Elvira Maria, Gubert, Vanessa Terezinha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701948/ https://www.ncbi.nlm.nih.gov/pubmed/34941096 http://dx.doi.org/10.1097/MD.0000000000028246 |
Ejemplares similares
-
A case report of successful treatment of necrotizing fasciitis using negative pressure wound therapy
por: Paula, Fabiana Martins, et al.
Publicado: (2019) -
Hepatotoxicity and hematologic complications induced by fusidic acid in a patient with hepatitis B cirrhosis: A case report
por: He, Zhong-Fang, et al.
Publicado: (2019) -
Instruments for the assessment of patient adherence to oral anticoagulation with warfarin protocol for a systematic review
por: da Silva Praxedes, Marcus Fernando, et al.
Publicado: (2019) -
Does washing medical devices before and after use decrease bacterial contamination?: An in vitro study
por: Nai, Gisele Alborghetti, et al.
Publicado: (2021) -
Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative
por: Hunt, Nicholas B., et al.
Publicado: (2022)